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SUMMARY
Objectives: As a starting point, a vast variety of 200 technical papers and documents published during the ten years 1999-2008, 
from Brazilian and international organizations dedicated to the control of leprosy, was taken. A study was then undertaken to investigate 
its future evolutive possibilities by employing resources obtained from scenario analyses. Design: The methodological reconstruction 
in use was of a qualitative nature, based on a bibliographic review and content analysis techniques. The latter were employed in 
a documental, categorical, contingent, frequency-based format, in compliance with appropriate and pertinent conditions. Results: 
Nowadays, important elements on epidemiological and operational aspects have been regained, as well as respective perspectives. 
Conclusions: A projection is made towards the fact that the maintenance of the disease’s present incidence levels constitute economic 
and sanitary challenges that confront issues ranging from the neoliberal model of global societal organization to specific competences 
of actions taken by health teams in the field.
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INTRODUCTION
Leprosy continues to be a great Public Health problem in Brazil, 
as it is recognized even by sectoral authorities, those responsible for 
the control of disease in our country1. Efforts have been hampered by 
gaps in information relating to important specific aspects, exacerbated 
by the absence of appropriate instruments for evaluation and routine 
systematic analysis20. 
The exploration of possible health evolutions within the next few 
years has been drawn to attention in several important publishing 
materials, including the official periodical issued by the World Health 
Organization (WHO) who published a review13 on the health dimension 
of 31 previous studies on global scenarios. The review showed three 
possible prospective alternatives expected: i) infectious diseases; ii) 
medical technology, and iii) sustained health. Focusing on the first, it 
deals with the reemergence of former diseases or the appearance of 
new ones, and stems from social, political and economic factors which 
lead to human movements that facilitate new contact with microbes, 
which are associated to changes concerned with productive activities, 
such as deforestation, road construction and changes in irrigation 
systems. Microbial resistance, personal behavior and environmental 
pressures relate to the second period, which, if accompanied by social 
balance, will go through a time when: a) public policies shall actually 
protect the natural needs of future generations; b) global surveillance 
and monitoring shall lead to the eradication of disease; c) despite 
the aging process of the world’s population, health will be easily at 
hand and, “moreover, disparities among poor and rich countries shall 
eventually disappear”. 
Under this line of scenario analysis, leprosy control has been 
intensely analyzed by some experts14. In fact, an epidemiological model 
was adopted based on figures regarding new detected cases obtained 
from 1985, using national data published by the WHO’s Weekly 
Epidemiological Records, working with 14 countries where such values 
were equal or greater than 2000 in 1998. The respective temporal series 
were shown to be rather unstable, thus reflecting - although with some 
delay - changes that were introduced to the policies of control. Three basic 
evolutive incidence standards were obtained: i) stable or rising, as for the 
cases of Brazil and India; ii) a sudden rise, as for Myanmar, Nepal, and 
Madagascar, and iii) a decline, as for the Philippines, China, and Vietnam; 
fluctuations in Guinea were too harsh. It was observed that, as several 
possible scenarios are simulated, the time corresponding to the reduction 
of 50% was seven to 14 years, according to differentiated interventions 
of the BCG vaccination, universal adoption of multidrug therapy (MDT) 
and socioeconomic changes; “the most important conclusion is the 
slow rhythm of disappearance in all the scenarios taken into account”. 
Given that the elimination of such condition received WHO attention, 
which differs from concepts conferred among others, it is recognized15 
that “sick people with no current urge for treatment, though possibly 
physically impaired, were removed from formal records” and, therefore, 
will continue to coexist with the disease.
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METHODOLOGY
As a starting point, a vast variety of 200 technical papers and 
documents published during the ten years 1999-2008, from Brazilian 
and international organizations dedicated to the control of leprosy, was 
taken. A study was then undertaken to investigate its future evolutive 
possibilities by employing resources obtained from scenario analyses. 
The methodological reconstruction in use was of a qualitative nature, 
based on a bibliographic review and content analysis techniques. The 
latter were employed in a documental, categorical, contingent, frequency-
based format, in compliance with appropriate and pertinent conditions.
EPIDEMIOLOGICAL ASPECTS
The reasons for the inaccuracy of the information obtained from 
registered prevalence studies have become of common knowledge. In 
addition to the so-called epidemiological “iceberg” due to low coverage 
by health services, the first question posed refers to patients in relapse or 
drug-resistant bacillus carriers, who are both ordinarily discharged from 
hospital. Inconsistencies when defining cases and diagnoses formulated 
under different criteria make comparisons between successive years 
or different regions a difficult experience, “if not impossible”. Point 
prevalence rates, i.e., a day defined in the year, as it is employed in 
leprosy, are also known to be affected by the duration of the condition, 
as they do not consider patients who undergo treatments lasting less than 
one year (currently the paucibacillary and probably the multibacillary 
in the future).
Indignation is concentrated in an official document issued by the 
WHO22, which quotes “non-existing patients” regarding a “diagnosis 
validation study” carried out in several regions of India: two “individuals 
with significant clinical experience” reviewed patients initially evaluated 
by health professionals in order to check the diagnostic accuracy and 
they discovered that approximately 30% of diseased persons in Delhi’s 
clinic hospitals could not be confirmed at the addresses provided, which, 
in a few cases, were even fictitious. The author begins by questioning the 
qualification of “validation” ascribed to research, as this category does 
not solely imply consideration with an independent evaluator, but also 
with independent instruments, which, for leprosy, consist of skin smear, 
biopsy, and application of Polymerase Chain Reaction (PCR) in order 
to detect bacillary DNA. 
The second criticism is directed towards the terminology created 
for “non-existing patients”, as everyone working with leprosy knows 
that many “existing patients” use the mistaken address strategy to 
minimize the effects brought on by stigma and ostracism either for 
themselves or their families. The third factor that generated confusion 
was the recommendation according to which 1/3 of the diseased should 
be discharged from the record when, in compliance with the previously 
mentioned argument, these patients are the ones in greater need of record 
and follow-up.
The lack of acquiescence would be even greater if information 
circulated about a few current practices that are legitimated as MDT is 
adopted. For instance, the immediate discharge of the active record of 
patients presenting incomplete treatment who have been absent from a 
health care unit for over a year, as revealed during the consideration of 
the favorable impact of such a therapeutic scheme in the Regional Health 
Department of Juiz de Fora, an inland city in Brazil, with nearly half a 
million inhabitants23.
Control of patients’ contacts continues to be an important question to 
be resolved: in Brazil, even in epidemiologically well surveilled regions, 
it is usually not higher than 1/3 of registered notifications26.
In specific reference to the African reality, it has been found out3 
that official figures can often provide an “overoptimistic” image of the 
situation. As quoted by the authors, a fair example is noticing that the 
number of records in many countries, at the end of the year, is smaller 
than the one of multibacillary cases detected during the period. Well, 
if leprosy takes on any importance, that is owing to the incapacities it 
presents: these “are supposed to attract a lot more attention than they 
presently receive”. 
As SOUTAR24 puts it, “it is possible to suggest that past failures 
related to other control initiatives, such as, for example, the ones of 
malaria and tuberculosis, contain lessons that WHO might as well 
perceive as far as leprosy elimination is concerned”.
OPERATIONAL ASPECTS
Perseverating through the specificities of leprosy, SAUNDERSON21 
provides quite indispensable additional elements. Amongst the “manifold 
challenges” that are bound to appear, he envisages that the first to show up 
with recent concern is to maintain sufficiently trained health professionals 
as much as taking action against the disease in endemic countries. 
Within the presented context, it is clear that the ongoing globalized 
neoliberal model features the shrinking of the State, deletion of the 
worker’s social and occupational welfare conquests, support to the action 
of generalists to the detriment of those holding specific competences, 
the fragility of human bases in economic relations - including the third 
sector, devoted to service rendering - , finally, by a wide range of factors 
that lead us to easily understand that “many experienced clinicians, from 
immediate assistance level up to the scopes of supervision and backup 
will no longer be working with leprosy patients in the next five to ten 
years” (in Brazil, we can say that this situation has already been true 
for at least the same period of time). Therefore, the control of the entire 
individual health care network is put at stake - from diagnosis up to the 
handling of complications - either on a quantitative or qualitative basis, 
both being aspects of the highest relevance. 
As a complement, following Saunderson’s thinking, how should 
young professionals learn to examine, treat and guide leprosy carriers? 
Through digital technology resources provided by distance learning? 
Teleconferences invading the cyberspace? 
Quite straightforwardly in that respect, in a text published by the 
WHO Bulletin10 where any conflict of interest is denied, the existence of 
negative effects in the “campaign” to eliminate the disease are recognized, 
which should be confronted in the immediate future, focusing on those 
that refer to the personnel education agenda, research and interaction 
among services. The key category in such analysis is the mistake 
committed in understanding the proposal in terms of, if ever being 
eliminated, the disease falling back into importance. In an apparently 
ingenuous pragmatism, the following is put into question: “Who can 
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pursue a career regarding a disease that is considered to be extinct?” 
The mentioned scale of difficulties refers to the conditions to integrate 
control in local health care units, a guideline adopted by most countries 
- due to process economic reasons. Also at this level, it is true that 
qualified professionals are scarce as well as the facilities required (they 
quote the case of a Hindu province where there is a health care center for 
200 thousand people when these figures amount to 30 thousand in other 
regions). Surveillance needs to be the central strategy to be developed, 
mainly in areas where integration is found, even in different moments 
of deployment: either incidence must be meaningfully raised through an 
increase in detection or abandonment through the difficulties to go ahead. 
Within this context, an additional challenge appears: non-governmental 
organizations are particularly invited to redesign respective performances 
for the substitution of vertical actions. 
As a consequence, they predict hindrances to occur in activities 
which are to be maintained, i.e. in the identification of cases, treatment 
application, incapacity prevention, and determination as well as the 
conduction of neural lesions. In the first aspect, they admit that diagnosis, 
although simple, calls for competence in the formulation of differentials 
as well as in the perception of neural involvement (they highlight the fact 
that anesthetic changes are not found in one out of three multibacillary 
patients). 
As a complement, nosographic peculiarities become priorities as 
well, mainly the following: 
i)  increasing demand for recognition in communities and services, 
of cases presenting a high bacillary load, which call for at least 24 
months of MDT, as it is of common knowledge;
ii)  tendency for the adoption of operational schemes devoid of intake 
supervision, contrarily to what is adopted in relation to tuberculosis, 
a biologically similar mycobacteriosis that presents failed adherence 
in unmonitored regimens; 
iii)  gradually increasing the urge to assess the relapse rate five years 
after the introduction of the drug; 
iv)  the event of reactive phenomena in one out of three multibacillary 
patients, requiring primary health care units to supply immediate 
access to make corticoids available and a reference system for more 
complex centers, for which special conditions are required; 
v)  prevention of incapacities, devised to last for the patient’s whole life, 
which is critical to achieve control success as even nowadays most 
treatment events comprise ulcerations and other respective outcomes;
vi)  the fight against stigmatization and insertion in public social 
inclusion programs, in addition to a reduction in poverty and misery 
- conditions associated with the highest rates of disease. 
As a powerful manifestation of reality, World Health Organization 
stood out as it published a document regarding the global strategy to 
reduce leprosy in the morbidity of countries and also the maintenance 
of control activities.27 Clearly, its sense is, on one side, to confirm the 
previous Organization documents in relation to classic actions taken 
against the endemic disease; dialectically, when pursuing such a 
conservative principle, it innovates and in doing so implies recognizing 
that the condition follows its shameful course in the midst of populations. 
The central ideas are actually surprising: 
i)  In three years (2001 to 2003), only by considering official data and 
disregarding the old epidemiological prevalence “iceberg”18, nearly 
two million citizens were infected worldwide!
ii)  The campaign-prone approach must be banned! More clearly 
to “maintain control activities in the long run, the ‘campaign-
like’ approach must be reinterpreted towards a long-term service 
maintenance process against leprosy, which is able to deliver high 
quality, integrated services”.
iii)  “Specific competence in leprosy as well as its control must be 
maintained within both national and subnational levels”. 
Above all, voices questioning the resolutive MDT validity concerned 
with disease control and mainly physical sequelae have been heard once 
again, in a new approach of well-known controversies that appeared at a 
time when such strategy was introduced as a routine, redeeming measure9. 
Some of them point to the absence of evidence on how it reduces leprosy 
incidence and to the difficulty in separating its own effects from the 
action caused by confounding factors2. Specifically, they state that no 
consensus has been reached by experts concerning its early administration 
and prevention of incapacities.
In fact, this issue had already been closely examined and drawn into 
incisive conclusion25. Even in the sense that WHO ascribes to “cure” 
as the “successful conclusion of a given evolution with MDT”, if cure 
is attained in levels up to 67% for paucibacillary patients and 38% for 
the multibacillary and such situation cannot be due to drug resistance, 
then the medication at issue is not able to solve the endemic situation. 
Furthermore, it is said that the cure by MDT, therefore, in addition to 
being mistaken, leads to serious outcomes, such as drawing attention away 
from more severe situations associated with the disease. For the sake of 
clarity and depth: “leprosy shall remain a health issue until the quality 
of life of those affected by this condition is meaningfully enhanced”.
Then, how to rebuild it? It is emphatically sustained6 that the future 
of collective issues posed by leprosy will only find a solution through 
the integration to general health care services. Indeed, reports thereto 
are not scarce in respective technical literature, either in Brazil7 or in 
other countries17 and even in terms of operational research, with a long 
description about how a non-governmental organization took action in 
India19.
PERSPECTIVES
It is this effervescence of a leper’s singular situation, which is 
visible before perceptive eyes that the disease tends to follow through. 
Everlasting for so many individuals in the past, present and future, such 
situations cannot be forgotten or solely dealt with by means of bandaging. 
They make up elements from greater units to be considered in a non-
segmented mood. They are inseparable parts of subjects who, on their 
turn, interact in society. They live together even when walls and fences 
are built in-between.
In other terms, a reference is made here to the need to get over 
previously mentioned gaps and stumbling blocks, the search for and 
discovery of other prophylactic measures and therapies, which are not 
only centered in medicative action against the bacillus in a mechanical 
and isolated way. 
As a solution, there is the synthesis that combines research in 
fundamental science and investigative development devoted to practical 
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control aspects28. This speech would refer to the evolution of microbial 
genomes, pathogen-host interactions, susceptible genetics, biological 
instruments against transmission blocks, drug resistance, detection of 
soluble cytokines, comparative genomics, molecular epidemiology at last 
directly, bacillary neurotropism and immunology as priorities requiring 
high dedication and financing. 
Within this context, the rediscovery made by the contribution of the 
academic community played by systematic physical activity practice for 
primary, secondary and tertiary leprosy prevention was a conquest that is 
disclosed in few, remote parts of the world. As an element used previously 
to its full extent and successfully for decades inasmuch as it refers to 
non-transmissible diseases, it has only recently been reconsidered in 
relation to transmissible illnesses. By deconstructing misunderstandings 
derived from previous views8, leprosy has deserved special attention in 
such a respect that if it is not taken into account as a priority in poor 
countries, it is hardly supposed to be taken seriously in developed ones, 
where it is not the priority of health policies. An important way to be 
taken, in that sense, is the one pointed out in Brazil by MONTEIRO & 
GONÇALVES16 in their investigation in a hospital context. They found 
out that, although physical activity may be presented as a risk factor for 
the disease outbreak and development, it also means, on the other hand, 
a protective factor concerned with neuritis events. It is also undeniable 
that there still is a lot to be known in that respect as well.
It is worth quoting that it is a matter of providing people with practical 
intervention, which, under specific interaction features, outdoes isolated 
pedagogic, playful, competitive or biologic aspects. When incorporating 
new perspectives, personal as well as social aspects of inclusion in society 
should be dealt with. Specifically, the rehabilitation process would lose its 
strict meaning of “habilitating again” but it would start to favor personal 
autonomy by respecting the characteristics of what is experienced by 
each individual.11
 
As recalled12, the guidance “philosophy” towards inclusion goes 
through an enhanced autonomy of people in disadvantage, with 
interventional participation as well as collaborative participation. 
Objectively, social environments do not need to be mandatorily adapted 
because when these users are treated for their disadvantages, they become 
active from their personal diversities in needs and expectations. In other 
words, focus passes by and goes beyond strictly environmental adaptations.4 
CONCLUSIONS
1. It was possible to specify a way to apply the qualitative 
methodology of scenario construction in order to give a sense of 
future to the evolution of leprosy control among us in distinguished 
epidemiological and operational aspects.
2. From different perspectives, including that of the World Health 
Organization, it is estimated that, unlike reiterating forecasts, leprosy is 
not supposed to be eliminated as a public health problem in the near future. 
3. Within this unsuccessfulness, in opposition to previous 
manifestations made by sectoral leaders, Brazil is one of the most 
remarkable countries. Several authors mention, among respective causes, 
the low prioritization conferred upon the actions of disease control to 
follow through and put the health service network into practice. 
4. It is recognized that the internationally adopted strategy of 
multidrug therapy presented positive outcomes as to its complete 
application (i.e. the cure, according to the WHO) to over 10 million 
people. However, important shortcomings remain, mainly non-reduction 
of endemic disease and negative balance generated by campaign-like 
activity adopted by the strategy. In relation to that, it is recognized as being 
absolutely necessary to overcome some of its most serious consequences. 
Reduction and non-replacement of qualified professionals is one of these, 
as well as the progressive absence of public permanent health services 
in control of the disease.
5. The number of infected people is great in comparison to the 
reduction of specialized centers, which has been observed regarding 
treatment units for the disease and its derivatives. Clearly phrased, 
the greatest fear is that the population grows simultaneously with the 
decreased resources and interest for the purposes of handling and control.
6. A possible alternative that is interpreted as a solution might be 
political decisions towards making contemporary scientific and social 
development also suitable for specific issues of the disease.
RESUMO
Controle da hanseníase: perspectivas e aspectos epidemiológicos e 
operacionais
Objetivos: A partir de acervo de 200 textos acadêmicos e de 
documentos de organismos nacionais e internacionais voltados ao 
controle da hanseníase publicados no período de 1999 a 2008, procurou-
se estudar respectivas possibilidades evolutivas futuras, empregando-se 
os subsídios do recurso de análise de cenários. Métodos: A reconstrução 
metodológica adotada foi de natureza qualitativa, fulcrada nas técnicas de 
revisão bibliográfica e análise de conteúdo. Esta última foi empregada na 
tipificação documental categorial frequencial contigencial, de acordo com 
devida fundamentação pertinente. Resultados: Recuperaram-se elementos 
atuais importantes de natureza epidemiológica e operacional, bem como 
de respectivas perspectivas. Conclusões: Projeta-se que a manutenção 
dos coeficientes de incidência da doença coloca reptos econômicos e 
sanitários a desafiar desde o modelo neoliberal de organização societária 
mundial até competências específicas das ações das equipes de saúde 
em campo. 
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